Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Four mouthwash options to help sockets heal after removal of an impacted lower wisdom tooth.

Official title: A Randomized Controlled Trial on the Effect of Different Types of Mouthwash on the Healing of Extraction Sockets

Run by University of Jordan · NCT06587880 · Data updated 2026-11-12

This study will test whether four mouthwashes — Bone Bioactive Liquid, hyaluronic acid, chlorhexidine, or warm saline — help socket healing and improve quality of life after surgical removal of an impacted lower wisdom tooth in adults.

More Postoperative Complications trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Jordan
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Amman)
StatusRecruiting
StartedAugust 10, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMay 7, 2026
Trial IDNCT06587880 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with a unilateral impacted mandibular third molar requiring surgical extraction with bone removal and an adjacent second molar are the ideal candidates.

Probably not a fit

Patients with soft-tissue-only impactions not needing bone removal, active oral infection, recent antibiotic use, uncontrolled systemic disease, immune deficiencies, prior head/neck radiotherapy, or certain medications are excluded and unlikely to benefit from these interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with a unilateral impacted mandibular third molar that requires bone removal are randomized to one of four postoperative rinses: Bone Bioactive Liquid (BBL), chlorhexidine digluconate (CHX), hyaluronic acid (HA), or warm saline mouth rinse (WSMR). The trial tracks extraction socket healing, postoperative complications, and patient-reported quality of life across follow-up visits. Standardized surgical technique and exclusion criteria (for example, recent antibiotics, active infections, immune compromise, or prior head/neck radiotherapy) are used to reduce confounding. Outcomes will compare healing rates, complication frequency, and patient comfort between the four groups.

Why it matters

Potential benefit: If effective, one or more mouthwashes could speed socket healing, reduce postoperative complications, and improve comfort and quality of life after third molar extractions.

How similar studies have gone: Chlorhexidine and saline rinses are well established for reducing postoperative issues after extractions, hyaluronic acid has emerging supportive evidence, and Bone Bioactive Liquid is relatively novel for socket healing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female patients aged 18 years and older who have a unilateral impacted mandibular third molar that is indicated for extraction with bone removal and the presence of an adjacent second molar.

Exclusion Criteria:

* Soft tissue impaction that will not need any bone removal.
* Presence of any acute oral infection including active Pericoronitis.
* Patients who have undergone radiotherapy in the head and neck region, chemotherapy or systemic long-term corticosteroid treatment.
* Patients receiving medications known to induce gingival hyperplasia; anticonvulsant (phenytoin), immunosuppressant (cyclosporine A), and various calcium channel blockers (nifedipine, verapamil, diltiazem).
* Patients who have taken systemic antibiotics less than 3 months prior to baseline.
* Presence of uncontrolled diabetes, severe nutritional deficiencies and endocrine disturbances.
* Presence of immune deficiency or any immune disease.
* Intravenous bisphosphonates or Oral bisphosphonate intake for more than 3 years.
* Smokers and alcoholics.
* Pregnant or lactating females.
* Hypersensitivity to one of the ingredients listed in any of the mouthwashes, especially chlorhexidine as reactions to this has been reported in the literature.

Where it's running

  • University of Jordan hospital
    Amman, Jordan
    Recruiting

Study contacts

  • Principal investigator: Ahmad Hamdan, Ph.D. in Periodontics — Faculty of Dentistry - University of Jordan
  • Study coordinator: Ahmad Hamdan, Ph.D. in Periodontics
  • Email: Ahmad.hamdan@ju.edu.jo
  • Phone: + 962779099199

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.